Sec. 3. Findings; sense of the House of Representatives regarding diabetes prevention under the Medicaid program
122 words·~1 min read·
/bill/113/hr/962/ih/section-3A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Congress makes the following findings: The prevalence and cost of diabetes is a significant concern for State Medicaid programs. By 2021, the Medicaid program is expected to cover 13,000,000 people with diabetes and about 9,000,000 people who may have pre-diabetes. By 2021, States will spend an estimated $83,000,000,000 on individuals with diabetes or pre-diabetes. The National Diabetes Prevention Program, as established by the Centers for Disease Control and Prevention, has been proven to reduce the onset of diabetes in at-risk adults by 58 percent, using a cost-effective, community-based intervention.
It is the sense of the House of Representatives that the National Diabetes Prevention Program presents an opportunity for States to reduce the incidence of diabetes among individuals enrolled in their Medicaid programs.